Non-allergic Rhinitis

  • Glenis K. Scadding
Part of the Allergy Frontiers book series (ALLERGY, volume 3)


Nonallergic rhinitis comprises a variety of conditions, only some of which are inflammatory. Careful history-taking (including any symptom relationship to occupation), endoscopic nasal, chest and general examination plus relevant tests are needed to categorize the patient as far as possible in order to determine treatment. Those with eosinophilic secretions respond to topical intranasal corticosteroids. When known causes (infectious, hormonal, drug-induced, secondary to gastro-oesophageal reflux, etc.) are excluded there remains a third of patients with unexplained “idiopathic rhinitis” which is probably largely neurogenic, but as yet ill understood. The term vasomotor rhinitis is misleading and should be abandoned as vascular changes are not involved and the phenomenon of nasal mucosal hyper- reactivity occurs in allergic as well as nonallergic rhinitis.


Allergic Rhinitis Chronic Fatigue Syndrome Allergy Clin Immunol Nasal Polyp Chronic Rhinosinusitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bousquet J, Van Cauwenberge P, Khaltaev N. Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001 Nov;108(5 Suppl):S147–334. Review.PubMedCrossRefGoogle Scholar
  2. 2.
    Temprano J, Dykewicz M. Nonallergic Rhinitis. In Rakel and Bope. Conn's Current Therapy 2005, pp. 236–40. Elsevier. 2005.Google Scholar
  3. 3.
    Powe DG, Jones NS. Local mucosal immunoglobulin E production: does allergy exist in non-allergic rhinitis? Clin Exp Allergy. 2006 Nov;36(11):1367–72.PubMedCrossRefGoogle Scholar
  4. 4.
    Jacobs RL, Freedman PM, Boswell RN. Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol. 1981 Apr;67(4): 253–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Settipane GA, Klein DE. Non allergic rhinitis: demography of eosinophils in nasal smear, blood total eosinophil counts and IgE levels. N Engl Reg Allergy Proc. 1985;6(4):363–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Rupp GH, Friedman RA. Eosinophilic nonallergic rhinitis in children. Pediatrics. 1982 Sep;70(3):437–9.PubMedGoogle Scholar
  7. 7.
    Varga EM, Jacobson MR, Masuyama K, Rak S, Till SJ, Darby Y, Hamid Q, Lund V, Scadding GK, Durham SR. Inflammatory cell populations and cytokine mRNA expression in the nasal mucosa in aspirin-sensitive rhinitis. Eur Respir J. 1999 Sep;14(3):610–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C. Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy. 2007;93:214–36.PubMedCrossRefGoogle Scholar
  9. 9.
    Nelson BL, Jacobs RL. Response of nonallergic rhinitis with eosinophilia (NARES) syndrome to 4% cromolyn sodium nasal solution. J Allergy Clin Immunol. 1982 Aug; 70(2):125–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Swierczyńska M, Strek P, Skladzień J, Nizankowska-Mogilnicka E, Szczeklik A. Nonallergic rhinitis with eosinophilia syndrome: state of knowledge. Otolaryngol Pol. 2003;57(1): 81–4.PubMedGoogle Scholar
  11. 11.
    Ragab S, Parikh A, Darby YC, Scadding GK. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy. 2001 Sept;31(9):1385–91.PubMedCrossRefGoogle Scholar
  12. 12.
    Pitkaranta A, Puhakka T, Makela MJ, Ruuskanen O, Carpen O, Vaheri A. Detection of rhinovirus RNA in middle turbinate of patients with common colds by in situ hybridization. J Med Virol. 2003 June;70(2):319–23.PubMedCrossRefGoogle Scholar
  13. 13.
    Wald ER, Guerva N, Byers C. Upper respiratory tract infections in young children: duration and frequency of complications. Paediatrics. 1991;87:129–33.Google Scholar
  14. 14.
    Turner BW, Cail WS, Hendley JO, Hayden FG, Doyle WJ, Sorrentino JV, Gwaltney JM Jr. Physiologic abnormalities in the paranasal sinuses during experimental rhinovirus colds. J Allergy Clin Immunol. 1992 Sept;90(3 Pt 2):474–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Berg O, Carenfelt C, Rystedt G, Anggard A. Occurrence of asymptomatic sinusitis in common cold and other acute ENT infections. Rhinology. 1986;24:223–5.PubMedGoogle Scholar
  16. 16.
    Fokkens WF, Lund VJ, Mullol J et al. European Position paper on Chronic rhinosinusitis and nasal polyposis. Rhinology. 2007;supplement 20.Google Scholar
  17. 17.
    Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN. Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun. 2007 Jan;75(1):83–90. Epub 2006 Nov 6.PubMedCrossRefGoogle Scholar
  18. 18.
    Harvey RJ, Lund VJ. Biofilms and chronic rhinosinusitis: systematic review of evidence, current concepts and directions for research. Rhinology. 2007 Mar;45(1):3–13.PubMedGoogle Scholar
  19. 19.
    Scadding GK, Caulfield H. Paediatric Chronic Rhinosinusitis. In Scott Brown (ed). Otorhinolaryngology Hodder Arworld, London 2007. Hodder Arnold, LondonGoogle Scholar
  20. 20.
    Patella V, Florio G, Petraroli A, Marone G. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol. 2000 Jan 15;164(2):589–95.PubMedGoogle Scholar
  21. 21.
    Marone G, Florio G, Triggiani M, Petraroli A, de Paulis A. Mechanisms of IgE elevation in HIV-1 infection. Crit Rev Immunol. 2000;20(6):477–96.PubMedGoogle Scholar
  22. 22.
    Schubert MS. Allergic fungal sinusitis. Otolaryngol Clin North Am. 2004 Apr;37(2):301–26.PubMedCrossRefGoogle Scholar
  23. 23.
    Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope. 2000 May;110(5 Pt 1):799–813.PubMedCrossRefGoogle Scholar
  24. 24.
    Orlandi RR, Thibeault SL, Ferguson BJ. Microarray analysis of allergic fungal sinusitis and eosinophilic mucin rhinosinusitis. Otolaryngol Head Neck Surg. 2007 May;136(5):707–13.PubMedCrossRefGoogle Scholar
  25. 25.
    Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004 June;113(6):1122–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, Lund V, Fokkens WJ. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006 Nov;118(5):1149–56.PubMedCrossRefGoogle Scholar
  27. 27.
    Garnier R, Villa A, Chataigner D. Occupational rhinitis Rev Mal Respir. 2007 Feb;24(2): 205–20.Google Scholar
  28. 28.
    Aguwa EN, Okeke TA, Asuzu MC. The prevalence of occupational asthma and rhinitis among woodworkers in south-eastern Nigeria. Tanzan Health Res Bull. 2007 Jan;9(1):52–5. Rhinology. 2007 Mar;45(1):40–6.PubMedGoogle Scholar
  29. 29.
    Di Stefano F, Di Giampaolo L, Verna N, Di Gioacchino M. Respiratory allergy in agriculture. Allerg Immunol (Paris). 2007 Mar;39(3):89–100.Google Scholar
  30. 30.
    Klusackova P, Lebedova J, Pelclova D, Salandova J, Senholdova Z et al. Occupational asthma and rhinitis in workers from a lasamide production line. Scand J Work Environ Health. 2007 Feb;33(1):74–8.PubMedGoogle Scholar
  31. 31.
    de Fátima MaÇãira E, Algranti E, Medina Coeli MendonÇa E, Antônio Bussacos M. Rhinitis and asthma symptoms in non-domestic cleaners from the Sao Paulo metropolitan area, Brazil. Occup Environ Med. 2007 July;64(7):446–53. Epub 2007 Feb 15.PubMedCrossRefGoogle Scholar
  32. 32.
    Airaksinen L, Tuomi T, Vanhanen M, Voutilainen R, Toskala E. Use of nasal provocation test in the diagnostics of occupational rhinitis. Rhinology. 2007 Mar;45(1):3–13.Google Scholar
  33. 33.
    Peters J, Pickvance S, Wilford J, Macdonald E, Blank L. Predictors of delayed return to work or job loss with respiratory ill-health: a systematic review. J Occup Rehabil. 2007 June;17(2):317–26. Epub 2007 Feb 13.PubMedCrossRefGoogle Scholar
  34. 34.
    Sahin-Yilmaz AA, Corey JP. Rhinitis in the elderly. Clin Allergy Immunol. 2007;19:209–19.PubMedGoogle Scholar
  35. 35.
    Vayisoglu Y, Ozcan C, Pekdemir H et al. Autonomic nervous system evaluation using heart rate variability parameters in vasomotor rhinitis patients. J Otolaryngol. 2006 Oct;35(5):338–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Elsheikh MN, Badran HM. Dysautonomia rhinitis: associated otolaryngologic manifestations and characterization based on autonomic function tests. Acta Otolaryngol. 2006 Dec;126(11):1206–12.PubMedCrossRefGoogle Scholar
  37. 37.
    Baraniuk JN, Ho Le U. The nonallergic rhinitis of chronic fatigue syndrome. Clin Allergy Immunol. 2007;19:427–47.PubMedGoogle Scholar
  38. 38.
    Drouet M, Sabbah A, Le Sellin J, Bonneau JC, Fourrier E. Fernand Widal syndrome and sulfite intolerance. Therapeutic problems in general and ORL problems in particular. Allerg Immunol (Paris). 1990 Mar;22(3):90–6.Google Scholar
  39. 39.
    Vally H, Thompson PJ. Allergic and asthmatic reactions to alcoholic drinks. Addict Biol. 2003 Mar;8(1):3–11.PubMedCrossRefGoogle Scholar
  40. 40.
    Scadding GK. Rhinitis medicamentosa. Clin Exp Allergy. 1995 May;25(5):391–4.PubMedCrossRefGoogle Scholar
  41. 41.
    Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol. 2006 Oct;118(4):773–86; quiz 787–8. Epub 2006 Sep 1.PubMedCrossRefGoogle Scholar
  42. 42.
    Mastalerz L, Sanak M, Gawlewicz-Mroczka A, Cmiel A, Gielicz A, Szczeklik. Prostaglandin E2 systemic production in asthma patients with and without aspirin hypersensitivity. Thorax. 2007 June 21. Epub ahead of print.Google Scholar
  43. 43.
    Kim SH, Kim YK, Park HW, Jee YK, Kim SH, Bahn JW, Chang YS, Kim SH, Ye YM, Shin ES, Lee JE, Park HS, Min KU. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics. 2007 Apr;17(4):295–304.PubMedCrossRefGoogle Scholar
  44. 44.
    Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, Picado C, Scadding G, Kowalski ML, Setkowicz M, Ring J, Brockow K, Bachert C, Wohrl S, Dahlen B, Szczeklik A. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy. 2007 May 22. Epub ahead of print.Google Scholar
  45. 45.
    Macy E, Bernstein JA, Castells MC, Gawchik SM, Lee TH, Settipane RA, Simon RA, Wald J, Woessner KM. Aspirin desensitization joint task force aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol. 2007 Feb;98(2):172–4.PubMedGoogle Scholar
  46. 46.
    Page NA, Schroeder WS. Rapid desensitization protocols for patients with cardiovascular disease and aspirin hypersensitivity in an era of dual antiplatelet therapy. Ann Pharmacother. 2007 Jan;41(1):61–7. Epub 2007 Jan 2. Review.PubMedGoogle Scholar
  47. 47.
    Roll A, Wuthrich B, Schmid-Grendelmeier P, Hofbauer G, Ballmer-Weber BK. Tolerance to celecoxib in patients with a history of adverse reactions to nonsteroidal anti-inflammatory drugs. Swiss Med Wkly. 2006 Oct 28;136(43–44):684–90.PubMedGoogle Scholar
  48. 48.
    Philpott CM, El-Alami M, Murty GE. The effect of the steroid sex hormones on the nasal airway during the normal menstrual cycle. Clin Otolaryngol Allied Sci. 2004 Apr;29(2):138–42.PubMedCrossRefGoogle Scholar
  49. 49.
    Ellegard EK, Karlsson NG, Ellegard LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clin Allergy Immunol. 2007;19:305–21.PubMedGoogle Scholar
  50. 50.
    Shushan S, Sadan O, Lurie S, Evron S, Golan A, Roth Y. Pregnancy-associated rhinitis. Am J Perinatol. 2006 Oct;23(7):431–3. Epub 2006 Sep 25.PubMedCrossRefGoogle Scholar
  51. 51.
    Jeevanan J, Gendeh BS, Satpal S. Hashimoto's thyroiditis: a rare cause for rhinosinusitis. Med J Malaysia. 2004 Aug;59(3):428–30.PubMedGoogle Scholar
  52. 52.
    Mehrotra R, Singhal J, Kawatra M, Gupta SC, Singh M. Pre and post-treatment histopathological changes in atrophic rhinitis. Indian J Pathol Microbiol. 2005 July;48(3):310–3.PubMedGoogle Scholar
  53. 53.
    Sayed RH, Abou-Elhamd KE, Makhlouf MM. Light and electron microscopic study of primary atrophic rhinitis mucosa. Am J Rhinol. 2006 Sept–Oct;20(5):540–4.PubMedCrossRefGoogle Scholar
  54. 54.
    Schlosser RJ. Surfactant and its role in chronic sinusitis. Ann Otol Rhinol Laryngol Suppl. 2006 Sep;196:40–4.PubMedGoogle Scholar
  55. 55.
    Garcia GJ, Bailie NA, Martins DA, Kimbell JS. Atrophic rhinitis: A CFD study of air conditioning in the nasal cavity. J Appl Physiol. 2007 June 14;E-pub.Google Scholar
  56. 56.
    Krzeska-Malinowska I, Held-Ziolkowska M, Januszek G. Successes and failures of ozena's medical treatment. Otolaryngol Pol. 2006;60(6):845–8.PubMedGoogle Scholar
  57. 57.
    van Rijswijk JB, Blom HM, Fokkens WJ. Idiopathic rhinitis, the ongoing quest. Allergy. 2005 Dec;60(12):1471–81.PubMedCrossRefGoogle Scholar
  58. 58.
    Sanico A, Togias A. Noninfectious, nonallergic rhinitis (NINAR): considerations on possible mechanisms. Am J Rhinol. 1998 Jan–Feb;12(1):65–72.PubMedCrossRefGoogle Scholar
  59. 59.
    Lee C, Corren J. Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis. Expert Opin Pharmacother. 2007 Apr;8(5):701–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Georgitis JW, Banov C, Boggs PB, Dockhorn R, Grossman J, Tinkelman D, Roszko P, Wood C. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life. Clin Exp Allergy. 1994 Nov;24(11):1049–55.PubMedCrossRefGoogle Scholar
  61. 61.
    Bonadonna P, Senna G, Zanon P, Cocco G, Dorizzi R, Gani F, Landi M, Restuccia M, Feliciello A, Passalacqua G. Cold-induced rhinitis in skiers – clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol. 2001 Sept–Oct;15(5):297–301.PubMedGoogle Scholar
  62. 62.
    Kim KT, Kerwin E, Landwehr L, Bernstein JA, Bruner D, Harris D, Drda K, Wanger J, Wood CC. Pediatric Atrovent Nasal Spray Study Group. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Ann Allergy Asthma Immunol. 2005 Jan;94(1):73–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Eccles R, Pedersen A, Regberg D, Tulento H, Borum P, Stjarne P. Efficacy and safety of topical combinations of ipratropium and xylometazoline for the treatment of symptoms of runny nose and nasal congestion associated with acute upper respiratory tract infection. Am J Rhinol. 2007 Jan–Feb;21(1):40–5.PubMedCrossRefGoogle Scholar
  64. 64.
    Blom HM, Van Rijswijk JB, Garrelds IM, Mulder PG, Timmermans T, Gerth van Wijk R. Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study. Clin Exp Allergy. 1997 July;27(7):796–801.PubMedCrossRefGoogle Scholar
  65. 65.
    Scadding GK, Lund VJ. Investigative Rhinology. Taylor & Francis, London. 2004.Google Scholar
  66. 66.
    Huggins K, Brostoff J. Local production of specific IgE antibodies in allergic rhinitis patients with negative skin tests. Lancet. 1975;2:148.PubMedCrossRefGoogle Scholar
  67. 67.
    Carney A, Powe D, Huskisson R, Jones N. Atypical nasal challenges results in patients with idiopathic rhinitis: more evidence for the existence of ‘local allergy’. Con Exp Allergy. 2002;32:1436–40.CrossRefGoogle Scholar
  68. 68.
    Wedback A, Enbom H, Ericksson N et al. Seasonal non-allergic rhinitis (SNAR) – a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis. Rhinology. 2005;43:86–92.PubMedGoogle Scholar
  69. 69.
    Powe DG, Huskisson R, Carncy A et al. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31:864–72.PubMedCrossRefGoogle Scholar
  70. 70.
    Berger G, Goldberg A, Ophir D. The inferior turbinate mast cell population of patients with perennial allergic and nonallergic rhinitis. Am J Rhinol. 1997;11:63–6.PubMedCrossRefGoogle Scholar
  71. 71.
    Humbert M, Durham SR, Ying S et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against ‘intrinsic’ asthma being distinct immunopathologic entity. Am J Resp Crit Care Med. 1996;154:1497–504.PubMedGoogle Scholar
  72. 72.
    Humbert M, Durham SR, Kimmitt P et al. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol. 1997;99:657–65.PubMedCrossRefGoogle Scholar
  73. 73.
    Ying S, Humbert M, Meng Q et al. Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atonic and nonatopic asthma. J Allergy Clin Immunol. 2001;107:686–92.PubMedCrossRefGoogle Scholar
  74. 74.
    Powe DG, Mason M, Jagger C et al. ‘Entopy’: localised mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy. 2003;33:1374–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Glenis K. Scadding
    • 1
  1. 1.Consultant Allergist and RhinologistRoyal National TNE HospitalLondonUK

Personalised recommendations